01213nas a2200361   4500000000100000008004100001260001300042653001000055653000900065653003600074653002400110653001100134653001100145653001800156653003300174653001900207653000900226653001600235653002400251653003900275653001200314653001400326653001800340653001600358653004400374100001200418700001400430245004000444300001000484490000700494520033600501022001400837       1985                            d  c1985 Mar10aAdult10aAged10aCentral Nervous System Diseases10aErythema Multiforme10aFemale10aHumans10aLichen Planus10aLupus Erythematosus, Discoid10aLupus Vulgaris10aMale10aMiddle Aged10aPemphigoid, Bullous10aPeripheral Nervous System Diseases10aPrurigo10aPsoriasis10aSkin Diseases10aThalidomide10aVasculitis, Leukocytoclastic, Cutaneous1 aNaafs B1 aFaber W R00aThalidomide therapy. An open trial.  a131-40 v243 a<p>In an open trial, 35 patients suffering from a variety of dermatologic conditions were treated with thalidomide. The drug was shown to be a valuable addition to the therapeutic armamentarium; however, the occurrence of a peripheral neuropathy will limit its use just as its teratogenic side effects have done for many years.</p>  a0011-9059